OSCR vs. GL, KNSL, BNT, BNRE, VOYA, JXN, ESNT, FG, ACT, and BWIN
Should you be buying Oscar Health stock or one of its competitors? The main competitors of Oscar Health include Globe Life (GL), Kinsale Capital Group (KNSL), Brookfield Wealth Solutions (BNT), Brookfield Reinsurance (BNRE), Voya Financial (VOYA), Jackson Financial (JXN), Essent Group (ESNT), F&G Annuities & Life (FG), Enact (ACT), and The Baldwin Insurance Group (BWIN). These companies are all part of the "insurance" industry.
Oscar Health vs.
Oscar Health (NYSE:OSCR) and Globe Life (NYSE:GL) are both finance companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, community ranking, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.
Globe Life has a net margin of 18.53% compared to Oscar Health's net margin of 0.28%. Globe Life's return on equity of 22.32% beat Oscar Health's return on equity.
Oscar Health currently has a consensus price target of $20.21, indicating a potential upside of 42.86%. Globe Life has a consensus price target of $135.60, indicating a potential upside of 4.51%. Given Oscar Health's higher possible upside, equities research analysts plainly believe Oscar Health is more favorable than Globe Life.
75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 81.6% of Globe Life shares are owned by institutional investors. 25.1% of Oscar Health shares are owned by company insiders. Comparatively, 1.5% of Globe Life shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Oscar Health has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500. Comparatively, Globe Life has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.
Globe Life has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Globe Life, indicating that it is currently the more affordable of the two stocks.
Globe Life received 30 more outperform votes than Oscar Health when rated by MarketBeat users. However, 55.22% of users gave Oscar Health an outperform vote while only 39.88% of users gave Globe Life an outperform vote.
In the previous week, Globe Life had 12 more articles in the media than Oscar Health. MarketBeat recorded 18 mentions for Globe Life and 6 mentions for Oscar Health. Globe Life's average media sentiment score of 1.05 beat Oscar Health's score of 1.02 indicating that Globe Life is being referred to more favorably in the news media.
Summary
Globe Life beats Oscar Health on 13 of the 18 factors compared between the two stocks.
Get Oscar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oscar Health Competitors List
Related Companies and Tools
This page (NYSE:OSCR) was last updated on 3/26/2025 by MarketBeat.com Staff
Buy OSCR Stock Free OSCR Stock Alerts